Ottawa, Ontario, Canada – Greg Waite, CEO of InventionShare, announced that Circuit Seed, a new family of circuit building blocks for processing analog signals using fully digital components, will have a significant impact on current and future medical devices.
Circuit Seed is a building block technology that will dramatically enhance the overall performance of the current and next generation medical devices, as well as impact on all analog components relating to higher sensitivity, batteries and low power consumption, sensors, imaging, transmitting of RF signals, and size reduction.
Waite said, “What we have with Circuit Seed is such a breakthrough for medical manufacturing companies and manufacturers of the key components for medical devices. They can now have digital circuits processing analog signals and enhancing devices in at least a dozen different ways. Mobility, accuracy, speed and battery life are some of the key drivers and Circuit Seed's family of inventions will provide unique application opportunities. Making it easier to develop cost effective, groundbreaking products based on new circuit designs and applications will, ultimately, enable doctors, nurses, and hospital staff to improve the patient experience. Point of practice diagnostics is becoming more and more important, while at home monitoring and therapies are also seen as high growth markets.”
Circuit Seed provides the opportunity for: extended range, faster processing, better resolution, enhanced audio fidelity, reduced foot print, better signal reception, increased sensitivity, improved accuracy, and enhanced touch interaction. It can free up space for additional sensors, lower power consumption and, importantly, provide the inherent ability to extend battery life.
By 2020 the global healthcare industry will be a highly connected environment powered by large data networks, cloud computing, and mobile devices. There will be an increase in connected healthcare networks providing seamless integration between care providers, patients, pharmaceutical companies, health insurers, and other invested parties - anywhere in the world. With this model, healthcare will become more patient-centric, less expensive to provide, and more innovative. According to the report 'Global Wearable Medical Device Market Outlook 2020', analysts expect that the wearable medical device market will reach US$ 4.6 billion in the next four years - the industry will be pushing for smaller devices and for more circuits that will interact with, inform and help patients.
Waite said, “We have an opportunity to work with manufacturers of devices at either the manufacturer level, and through to their supply chain, or directly with semiconductor companies that are making the analog components for medical devices. The primary challenge for making a better product is reducing the analog footprint while providing superior analogy functionality. We have broken Moore’s law. This is not evolution, this is revolution.”
Circuit Seed inventions are founded on a mixture of decades of experience and creativity, supported by a robust portfolio of IP. Circuit Seed introduces a dramatic shift in the existing way of designing analog circuits, effectively eliminating many of the known shortcomings. Benefits include: unprecedented precision without precision parts; ultra-linear operation over an extreme dynamic range (>106); low noise, ultrahigh speed (analog at logic speed) and extreme low voltage (down to ~0.1V power supply); process parameter independence; compact footprint (amplifiers about the size of a couple of NAND gates); low power (~100uW for multi-GHz-range operation down to 10pW for KHz-range operation); and portable designs between ultra-deep sub-µm CMOS technology process nodes. This paradigm shift has eliminated the use of current mirrors or differential matched pairs with traditional bulky analog transistors while being able to recover from sleep mode at logic speed.
Simulation and silicon test results have demonstrated a dramatic reduction in power, better performance and higher accuracy, all with small integrated circuit footprints. The circuit designs are much simpler, reducing product costs with faster development, so less testing is required and there are fewer parts to assemble. These circuits are far more reliable in the newest CMOS processes, making Circuit Seed a real breakthrough all companies requiring digital circuits processing analog signals.
“We believe that a vast majority companies currently manufacturing components for the healthcare industry will be using some form of Circuit Seed application in their products as early as Q1 2017,” said Waite.
InventionShare is now looking for strategic partners who want to incorporate Circuit Seed technology into healthcare device product offerings, with the benefit of leveraging market share and profitability through competitive feature sets and design and manufacturing advantages leading to the next generation of medical devices.
InventionShare is a unique invention equity company that accelerates the global adoption of socially responsible game changing inventions to the benefit of inventors, companies, people and planet.